GGrantIndex
← Search

NOVEL PPAR-ALPHA/DELTA DUAL AGONIST ETI-039 TO TREAT PULMONARY FIBROSIS

$3,256,955FY2020Defense Health AgencyDOD

Epitracker, Inc.

Investigators

View source on USAspending →